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Cell deathMitochondria are known to actively regulate cell death with the ﬁnal phenotype of demise being determined
by the metabolic and energetic status of the cell. Mitochondrial membrane permeabilization (MMP) is a
critical event in cell death, as it regulates the degree of mitochondrial dysfunction and the release of
intermembrane proteins that function in the activation and assembly of caspases. In addition to the crucial
role of proapoptotic members of the Bcl-2 family, the lipid composition of the mitochondrial membranes is
increasingly recognized to modulate MMP and hence cell death. The unphysiological accumulation of
cholesterol in mitochondrial membranes regulates their physical properties, facilitating or impairing MMP
during Bax and death ligand-induced cell death depending on the level of mitochondrial GSH (mGSH),
which in turn regulates the oxidation status of cardiolipin. Cholesterol-mediated mGSH depletion stimulates
TNF-induced reactive oxygen species and subsequent cardiolipin peroxidation, which destabilizes the lipid
bilayer and potentiates Bax-induced membrane permeabilization. These data suggest that the balance of
mitochondrial cholesterol to peroxidized cardiolipin regulates mitochondrial membrane properties and
permeabilization, emerging as a rheostat in cell death.I Provincial, C/Villarroel 170,
z-Checa).
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Mitochondria play a central role in various forms of cell death which
are characterized by differential biochemical features that include apo-
ptosis (caspase-dependent and independent), necrosis and autophagy.
A key event in this role is the breakage of mitochondrial membranes,
particularly the outer mitochondrial membrane, which allows the
release of proapoptotic factors that engage the apoptosome resulting in
apoptotic cell death. Understanding the mechanisms leading to
mitochondrial membrane permeabilization (MMP) is thus central to
the design of strategies to control cell death. In pathologies associated
with enhanced cell death such as liver diseases (e.g. steatohepatitis) or
neurodegeneration (e.g. Alzheimer's disease), the therapeutic goal is to
prevent or ameliorate the extent of cell death. In contrast, in cancer the
primary interest is to kill tumor cellsmore efﬁciently sensitizing them to
current cancer therapy.Although amajor focus in theﬁeld has beenpaid
on the role of Bcl-2 family members in the regulation of MMP and cell
death [1,2], an increasingbodyof evidencepoints toa key roleof lipids in
the regulation of MMP and cell death susceptibility. In particular, mito-chondrial cholesterol has emerged as an important modulator of MMP
in response to apoptotic stimuli including hypoxia, TNF, amyloid beta
peptide (Aβ) or Bax, underlying the importance of this particular bilayer
component in disease pathogenesis, including alcoholic and nonalco-
holic steatohepatitis, Alzheimer's disease or hepatocellular carcinoma
[3,4]. Although the unphysiological accumulation of cholesterol shields
mitochondrial membranes impairing the bilayer permeabilization, as
shown in model membranes, this effect can be counterbalanced by the
presence of peroxidized cardiolipin, which is in turn regulated by the
availability of mitochondrial GSH (mGSH) [3]. Thus, mitochondrial
cholesterol plays a paradoxical role in cell death depending on the
regulation ofmitochondrial GSH (mGSH) transport, mGSHhomeostasis
and subsequent protection of cardiolipin from peroxidation. In this
review, wewill brieﬂy summarize the implications of the enrichment of
mitochondrial membranes in cholesterol and its impact in mitochon-
drialmembraneproperties,mGSH regulation, cardiolipin status, and cell
death.
2. Mitochondrial pathway of cell death
Apoptosis is a speciﬁc form of cell death which is essential for life
as it is required for embryonic development, tissue homeostasis and
immune defense. Dysregulation of apoptosis, however, contributes to
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apoptotic cell death are cysteine proteases, called caspases, thatwork in
a coordinated cascade to cleave key substrates that dismantle the cell
with characteristic biochemical features [5,6]. Apoptosis can occur
through two main pathways, the extrinsic pathway and the intrinsic
pathway. The former is initiated upon the binding of an extracellular
ligand to transmembrane death receptors of the TNF superfamily,which
leads to the assembly of the death-inducing signaling complex (DISC)
[7,8]. The DISC then activates an initiator caspase, which triggers the
enzymatic cascade that leads to apoptotic death. The intrinsic pathway
is also known as the mitochondrial pathway and is activated by stimuli
that lead to the permeabilization of mitochondrial outer membrane
(MOM) and the subsequent release of proteins, such as cytochrome c,
from themitochondrial intermembrane space (IMS), which initiate and
regulate caspase activation. Cytochrome c normally resides within the
cristae of the mitochondrial inner membrane (MIM) and is effectively
sequestered by narrow cristae junctions.Within theMIM, cytochrome c
participates in the mitochrondrial electron-transport chain, using
its haem group as a redox intermediate to shuttle electrons between
complex III and complex IV. However, in response to speciﬁc apoptotic
triggers, suchasDNAdamage, ormetabolic stress, the intrinsic apoptotic
pathway is activated and mitochondrial cytochrome c is released into
the cytosol [2]. This process is thought to occur in two phases, ﬁrst
the mobilization of cytochrome c and then its translocation through
permeabilized MOM, described below. In addition to cytochrome c,
other IMS proteins are mobilized and released into the cytosol. For
instance, the release of Smac/Diablo into the cytosol ensures the efﬁ-
ciency of caspase 3 activation in degrading target proteins through
inhibition of inhibitor of apoptosis proteins (IAPs) [9,10]. Furthermore,
the mitochondrial protein Omi/HtrA2 promotes cell death in a dual
fashion. Besides its IAP activity Omi/HtrA2 also functions as a serine
protease, contributing to both caspase-dependent and caspase-inde-
pendent cell death [11,12]. Moreover, other specialized mitochondria-
resident proteins, such as the apoptosis inducing factor (AIF) [13] and
endonuclease G [14], are translocated to the nuclei following their
release frommitochondria and promote peripheral chromatin conden-
sation and high molecular weight DNA fragmentation. An important
feature of apoptosis is its dependence on energy by sustained ATP
supply to support caspase activation [2,5,6].
In contrast to apoptotic cell death, necrotic cell death is characterized
primarily by the rapid loss of cellular membrane potential, which leads
to cytoplasmic swelling, rupture of theplasmamembrane, and cytolysis.
The extentofmitochondrial dysfunctionand the rupture ofMIM impairs
the ability of mitochondria to generate ATP, needed for the function of
homeostatic ion pumps/channels, and the generation of reactive
oxygen and nitrogen species (ROS/RNS), which in turn, can regulate
caspase activation [15]. The onset of necrotic cell death can also occur in
the extrinsic pathway by death receptors, such as TNF or Fas. FADD, a
DISC component, has been shown to be involved in TNF-induced
necrosis [16,17]. RIP1 also contributes to death receptor-induced
necrosis, as RIP1-deﬁcient T cells are also resistant to death induced
by TNF and Fas in the presence of caspase inhibitors [17]. The kinase
activity of RIP appears to be required for necrosis induction, although its
targets remain to be identiﬁed. Necrostatin-1, a small molecule that can
inhibit necrosis induced by RIP or by TNF/Fas in the presence of caspase
inhibitor [18], may be a valuable tool to disclose signaling pathways
involved in death receptor-mediated necrosis. Thus, while mitochon-
dria play a key role in the control of cell death, the phenotype of the
dying cell depends on themetabolic and energetic status of the cell that
determine the level and extent of caspase activation.
3. Mitochondrial membrane permeabilization and
cytochrome c release
The mechanisms of MMP and cytochrome c release from IMS have
been an intense area of research, whose understanding may beimportant to control cell death. Indeed, this is a critical issue because,
in addition to cytochrome c, other proteins are also released from the
intermembrane space into the cytosol, where they engage in a strategic
battle to promote or counteract caspase activation and hence cell
death, as described above. The intricacy of this pathway highlights
the central role of mitochondria in regulating cell death, regardless
of the phenotype of death (caspase-dependent apoptosis, caspase-
independent apoptosis, or necrosis). Since these proapoptotic proteins
are normally conﬁned in the IMS, the events that culminate in the
rupture of the physical barrier (MOM), which limits their release into
the cytosol, constitute a point-of-no-return in cell death [2]. While the
underlyingmechanisms are not completely understood, there has been
evidence for two possiblemechanisms leading to the breakage ofMOM:
themitochondrial permeability transition (MPT), and the permeabiliza-
tion of MOM without disruption of the inner membrane, which is
regulated by Bcl-2 family. The usually impermeable MIM prevents
unrestrained inﬂux of low-molecular-weight solutes into the mito-
chondria. The MPT features mitochondrial swelling, uncoupling and
MIM permeabilization to small solutes, which results in a colloidal
osmotic pressure that leads primarily to massive swelling of the mito-
chondrialmatrix sensitive to cyclosporine A [2,19,20]. As a consequence
of MPT theMOM ruptures and cytochrome c and other IMS proteins are
released into the cytosol. MTP is most likely assembled at the contact
sites of the MOM and the MIM and the actual components of the MTP
remain ill deﬁned. Although MPT has a deﬁnitive role in regulating
MMP, mitochondrial dysfunction and cell death, this mechanism seems
to play a minor role in apoptotic cell death as opposed to necrosis. For
instance, deﬁciency of VDAC isoforms or cyclophilin D, two essential
MPT components, does not prevent apoptosis induced by Bcl-2 family
members, but impairs Ca2+-mediated MPT and ischemia–reperfusion
necrosis [21–23]. Alternatively to MPT, Bcl-2 family members control
MOM permeabilization. Bcl2-family death agonists induce MOM
permeabilization, thereby promoting cytochrome c release, whereas
Bcl2-family death antagonists prevent it. Thus, Bcl2-family proteins
control mitochondrial integrity, regulate cytochrome c release and
intrinsic apoptosis [1]. Under non-apoptotic conditions, Bax is inactive
and present in the cytosol as a monomer. Following an apoptotic
stimulus, Bax is activated and translocates to themitochondria,where it
undergoes a conformational change and inserts into the MOM. Bax
oligomerization is associated with the formation of openings in the
MOM to allow the release of cytochrome c and other IMS proteins into
the cytosol, and hence Bax oligomerization is considered a critical
regulatory point in cell death [1,2]. In contrast to Bax, Bak resides on the
MOM rather than in the cytosol but, like Bax, it undergoes a confor-
mational change in response to apoptotic stimuli. This change allows
Bak to oligomerize, contributing to MOM permeabilization. One poten-
tial mechanism involved in the permeabilizing activities of Bax/Bak
oligomers is the formation of pores in MOM. However, attempts to
visualize these oligomers have shown that large clusters of Bax are
localized adjacent, but not on, the MOM [1]. An alternative model
suggests that the insertion of activated, oligomerized Bax and/or Bak
into the MOM creates a positive curvature stress on the membrane,
leading to supramolecular pores that include lipids in theMOM[24–26].
Clearly, understanding the mechanisms underlying MOM permeabili-
zation may provide novel strategies to regulate cytochrome c release
and hence apoptosis. The relative prevalence of these pathways in the
regulation of cell death is not deﬁnitively established. One important
feature of mitochondrial membrane permeabilization is the loss of
function resulting in the inability of mitochondria to synthesize ATP
through the oxidative phosphorylation. However, while the ﬁnal out-
come of mitochondrial dysfunction is cell death, as mentioned above,
the phenotype of death, apoptosis and/or necrosis, is dependent on the
level of cellular ATP as ATP is required for the efﬁcient assembly of the
apoptosome and/or the extent of ROS generation [1,2].
In addition to understanding the mechanisms leading to MOM
permeabilization to design strategies to control cell death, another level
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cytochrome c from IMS. It has been proposed that during mobilization
cytochrome c detaches from the MIM and dissociates from the
membrane phospholipid cardiolipin [27]. Indeed, it has been estimated
that a relatively low proportion of cytochrome c in the mitochondria
seems to be associated with cardiolipin, involving two major mecha-
nisms [27]. At physiological pH, cytochrome chas 8 positive net charges,
establishing an electrostatic bond with the anionic cardiolipin. In
addition, cytochrome c has a hydrophobic channel through which one
acyl chain of cardiolipin inserts. The other chainsof cardiolipin remain in
the membrane, thereby anchoring cytochrome c to the MIM [28]. One
mechanism involved in cytochrome c detachment from MIM involves
cardiolipin oxidation because oxidized cardiolipin has a lower afﬁnity
for cytochrome c than the unoxidized form [29,30]. Cardiolipin can be
oxidized by ROS, which are controlled by mitochondrial antioxidants
such as GSH [30,31] or by the cardiolipin–cytochrome c complex [32].
Detachment of cytochrome c fromcardiolipinmight also be triggered by
increased cytosolic Ca2+, which weakens the electrostatic interaction
between cytochrome c and cardiolipin. In addition, as described below,
oxidized cardiolipin modulates the biophysical properties of MOM to
allow oligomerized Bax to insert and permeabilized MOM [30].
In spite that only a small fraction of cytochrome c is bound to
cardiolipin (about 15%), the oxidation of this lipid is thought to impact
themobilization of cytochrome c fromMIM, although the relevance of
this step in the release of cytochrome c to the cytosol is controversial.
For instance, in isolated mitochondria, exposure to 50–80 mM K+, a
concentration of intracellular K+ that is within physiological limits,
causes the release of cytochrome c from the IMM [33]. In addition,
live-cell imaging has revealed no differences in the kinetics of the
release of cytochrome c compared with other IMS proteins in cells
undergoing apoptosis [34]. These results imply that cytochrome c
mobilization might not be required as an additional step in the release
of cytochrome c from the mitochondria. In addition, mobilization of
cytochrome c might also involve its removal from narrow cristae
junctions, although this speciﬁc issue is unsettled. In this regard, it has
been suggested that the remodeling of cristae is required in the
release of this interior pool of cytochrome c [35], and recent studies
correlated the disassembly of Opa1 oligomers, a structural deter-
minant of cristae morphology, with the remodeling of cristae [36].
However, recent data using three-dimensional electron microscope
tomograpy, have disclosed that cristae remodeling is not required for
efﬁcient release of cytochrome c [37]. Moreover, BH3-only proteins
Bid and Bim induced full cytochrome c release but only a subtle
alteration in cristae junctions, which involved the disassembly of
Opa1 complexes [38].
4. Cholesterol in mitochondrial membrane properties, MMP and
cell death
Cholesterol is a critical component ofmembraneswithkey structural
and functional roles [39]. Compared to plasmamembranemitochondria
are much less enriched in cholesterol with estimates of about 3–5% of
the total cholesterol cell load. However, this restricted pool of
cholesterol in mitochondria plays a fundamental physiological role
such as in the synthesis of bile acids in hepatocytes or steroidogenic
hormones in specialized tissues [3]. Given the role of cholesterol in the
regulation of membrane dynamics and physical properties, the
synthesis and supply of membrane cholesterol is highly regulated
under physiological conditions. Cholesterol is synthesized in the ER and
delivered to other organelles by a combination of vesicular and non-
vesicular transport processes [39,40]. Since cholesterol is very insoluble
in water, it must be shuttled by carriers. The mechanisms of non-
vesicular cholesterol transport are poorly understood, although there is
increasing evidence that this is the major route for cholesterol
movement between organelles. In the case of cholesterol trafﬁcking to
mitochondria, the best characterized example of non-vesicular mech-anism involves the steroidogenic acute regulatory protein (StAR),which
is the prototype for the StAR-related lipid transfer (START) family of
transport proteins. StAR plays an essential role in the delivery of choles-
terol to mitochondria, where it is used in steroid hormone synthesis in
steroidogenic tissues or in the acidic pathway of bile acid synthesis in
hepatocytes [39,41]. Cholesterol is known to regulate membrane
organization. In particular cholesterolmodulates the coexistencewithin
membranes of lipid-disordered and lipid-ordered phases, which regu-
lates membrane permeability and function of resident proteins. In this
regard, it has been shown that cholesterol loading in mitochondria
results in increased membrane order parameter which impacts nega-
tively in speciﬁc membrane carriers, such as the GSH transport system
without effect in others, including the S-adenosyl-L-methionine
transport system [42]. Since GSH is synthesized de novo exclusively in
the cytosol but not in mitochondria, the mitochondrial source of
GSH depends on its transport from cytosol by the 2-oxoglutarate and
dicarboxylates carriers, which have been previously characterized
[43,44]. Functional expression studies in Xenopus laevis oocytes
provided clear evidence that the 2-oxoglutarate carrier is highly sensi-
tive to mitochondrial membrane ﬂuidity loss induced by cholesterol
loading [44]. Coupled with previous ﬁndings showing low and high
afﬁnity components for themitochondrial transport of GSH into rat liver
mitochondria, the 2-oxoglutarate carrier accounts for the low afﬁnity
transport site with the dicarboxylate playing a minor role. Thus, one of
the functional consequences ofmitochondrial cholesterol enrichment is
the impairment of mitochondrial GSH (mGSH) transport which results
in its depletion in the mitochondrial matrix, promoting the stimulation
of mitochondrial ROS induced by death ligands (e.g. TNF) (Fig. 1). This
paradigmwould favor the peroxidation of cardiolipin by enhanced ROS,
which destabilizes the lipid bilayer potentiating MOM and subsequent
release of cytochrome c. Since GD3 is a key component of raft-like
domains and shown to promote MOM [15], it is conceivable that the
enhanced mitochondrial cholesterol loading may result also in the
enrichment of GD3 in speciﬁc domains of mitochondrial membranes
possibly associated with peroxidized cardiolipin, although this remains
to be established.
4.1. Mitochondrial cholesterol in liver diseases and neurodegeneration
One of the most common forms of liver disease worldwide is
steatohepatitis, which encompasses both alcoholic (ASH) and nonalco-
holic steatohepatitis (NASH). While the pathogenesis of these diseases
are obviously different, they exhibit indistinguishable histological
features and common underlying mechanisms of disease progression
that begin with hepatic steatosis. Although fat inﬁltration in these
diseases is heterogenous consisting primarily of triglyceride, free fatty
acids and cholesterol, recent studies have pointed to an emerging role
for cholesterol, particularly in mitochondria, in the progression from
steatosis to steatohepatitis as it sensitizes hepatocytes to inﬂammatory
cytokines (e.g. TNF/Fas ligand) [45]. Moreover, massive triglyceride
accumulation in the liver of transgenic mice overexpressing DGAT2 did
not impair insulin sensitivity, a hallmark feature of NASH [46]. In
addition, unchanged hepatic free fatty acid levels were reported in
patients with NASH compared to healthy controls, while the degree
of free cholesterol accumulation correlated with disease progression
[47,48]. The underlying mechanism for the sensitization of mitochon-
drial cholesterol-loaded hepatocytes to TNF/Fas and hence steatohepa-
titis involved the selectivemGSHdepletion, anoutcomealso observed in
models of ASH [43,45]. Two pieces of evidence supported this con-
tention. First, the replenishment of mGSH by permeable precursors,
such as GSH ethyl ester, protected mitochondrial cholesterol-loaded
hepatocytes induced by alcohol feeding or genetic models against TNF/
Fas-mediated cell death. Second, control hepatocytes selectively
depleted of mGSH reproduced the sensitization to TNF/Fas observed
in the nutritional and genetic models of hepatic steatosis characterized
by cholesterol accumulation. In this paradigm, we have observed that
Fig. 1. Cholesterol regulates the cardiolipin/peroxidized cardiolipin status. A, Under physiological settings the pool of mitochondrial cholesterol is low allowing unimpaired transport
of GSH into the mitochondrial matrix by the 2-oxoglutarate (2-OG) carrier, with aminor role for the dicarboxylate carrier (DIC), at least in rat liver mitochondria. In this scenario, the
generation of ROS by cell death stimuli such as TNF, hypoxia or Aβ, is controlled by GSH availability, ensuring the presence of intact cardiolipin inmitochondrial membranes. B, When
the trafﬁcking of cholesterol is stimulated as seen in different pathologies (e.g. ASH/NASH or Alzheimer's disease), the mitochondrial transport of GSH via 2-OG is impaired resulting
in GSH depletion which stimulates the generation of ROS in response to TNF causing cardiolipin peroxidation (CLOOH), which destabilizes the lipid bilayer and contributes to MOM
permeabilization (MOMP) mediated by Bax.
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generation of ROS via acidic sphingomyelinase-induced ceramide
generation, without inactivation of NF-κB-dependent survival pathway
[30]. Moreover, mGSH depletion potentiated TNF-induced cardiolipin
peroxidation, which facilitated the permeabilizing activity of oligomer-
ized BAX in the MOM (see below).
Neurodegeneration reﬂects a number of hereditary or sporadic
diseases characterized by progressive atrophy and neuronal loss, which
include major diseases such as Alzheimer's disease (AD), Parkinson's
disease (PD), and Huntington's disease (HD). AD is characterized by
progressive memory loss and cognitive impairment whose incidence
is associated with aging. Despite intense research, the molecular
pathogenesis of AD is still incompletely unknown. One of the main
features of AD involves the deposition in the brain of senile plaques,
consisting predominantly of the Aβ peptide of 40–42 amino acid, which
is thought to play a key role in AD [4]. Indeed, using longitudinal in
vivo multiphoton microscopy to sequentially image young APPswe/
PS1d9xYFP (B6C3-YFP) transgenic mice, it was observed that Aβ
plaques formed very quickly, within 24 h. The appearance of plaques
is followed by the activation and recruitment of microglia to this spe-
ciﬁc sites. Progressive neuritic changes ensue, leading to increasingly
dysmorphic neurites which appears within days to weeks [49]. Thus,
these ﬁndings critically establish that Aβ plaque formation precedes
disease progression [49]. In addition to aging, epidemiological observa-
tions identiﬁed hypercolesterolemia as a major risk factor for sporadic
AD [4,50,51]. In this regard, the role of statins in AD, however, has been
controversial, although theepidemiological evidence linking cholesterol
to AD has been supported by in vivo and in vitro data. Indeed, since the
amiloidogenic processing of the amyloid precursor protein by the
presenilin1/γ-secretase is thought to occur in speciﬁc microdomains of
the plasmamembrane, cholesterol enrichment favors the generation of
Aβ peptide and hence neurite degeneration [52]. Consistent with the
mitochondrial targeting of Aβ as a major mechanism involved in Aβ-
induced neurotoxicity, the speciﬁc role of mitochondrial cholesterol in
this context has been recently evaluated.Usinggeneticmousemodels of
cholesterol accumulation, mitochondrial cholesterol enrichment in
transgenic SREBP-2 and NPC1 knockout mice was observed which
determined enhanced susceptibility to Aβ-mediated neuroinﬂamma-
tion and neurotoxicity due tomGSH depletion [53]. Moreover, APP/PS1
transgenic mice exhibited enhanced mitochondrial cholesterol loading
and subsequent mGSH depletion. Isolated mitochondria from thesemice exhibited increased susceptibility to Aβ-mediated cytochrome c
and Smac/Diablo release, indicative of MMP, and caspase activation
compared to wild typemice. Of relevance, the onset of AD symptoms in
vivo were prevented by mGSH recovery with GSH ethyl ester, thus
pointing that strategies aimed to boost this particular pool of GSH may
be of potential relevance in AD.
4.2. Mitochondrial cholesterol and cancer therapy
Cancer cells exhibit critical metabolic transformations regarding
the cholesterol homeostasis best illustrated by the ability of solid
tumors to synthesize cholesterol under hypoxia, which contrasts with
the physiological requirement for oxygen in the transformation of
lanosterol into cholesterol via 9 redox reactions [3,39]. Moreover,
recent observations indicated that hypoxia stimulates the degradation
of HMG-CoA reductase, the rate-limiting enzyme in cholesterol syn-
thesis [54]. In addition to this continued cholesterol synthesis in
growing tumor cells, we have recently observed the stimulation of
cholesterol trafﬁcking to mitochondria from hepatocellular carcinoma
(HCC) cells due to the overexpression of StAR [55]. Previous studies
have shown that cholesterol enrichment of rat liver mitochondria
impairs the ability of atractyloside to induce MPT [56], which suggest
that mitochondrial cholesterol loading may actually account for the
recognized mitochondrial dysfunction occurring in cancer cells
(Fig. 2). In addition to this putative effect of cholesterol in the regula-
tion ofmitochondrial function of cancer cells, we focused on the role of
mitochondrial cholesterol in chemotherapy sensitivity and cell death
regulation. Indeed, HCC mitochondria exhibit increased membrane
order and resistance to Bax-mediatedMMP, which are reversed either
by cholesterol extraction with methylcyclodextrin or membrane
ﬂuidiﬁcation by A2C [55]. Observations in HeLa cells treated with
U18666A, which results in mitochondrial cholesterol loading, indicat-
ed a delayed release of Smac/Diablo and cytochrome c, as well as in
BAX oligomerization and partial protection against stress-induced
apoptosis [57]. Consistent with our ﬁndings in HCC, data from lipo-
somes entrapping ﬂuorescent dextrans indicated that the presence of
cholesterol in the bilayer impaired Bax-mediated permeabilization
due to the combination of reduced membrane dynamics and de-
creased Bax integration into the bilayer [55]. Moreover, the silencing
of StARdownregulatedmitochondrial cholesterol levels and sensitized
HCC cells to chemotherapy, similar to the ﬁndings observed with
Fig. 2. Paradoxical role of mitochondrial cholesterol in cell death. Since cholesterol regulates membrane dynamics and physical properties, the in situ enrichment in cholesterol
impairs mitochondrial membrane permeabilization via MPT induced in response to atractyloside, which acts via adenine nucleotide translocator (ANT), Ca2+ or ROS, as well as the
permeabilization of the outer membrane by active Bax. However, in pathological conditions associated with mitochondrial cholesterol trafﬁcking and accumulation in both the inner
and outer membranes via StAR expression potentiates mitochondrial membrane permeabilization in response to TNF/Fas, ROS, Bax or Aβ due to the mitochondrial GSH depletion. A
role for the StAR family member MLN64 in the delivery of cholesterol to mitochondria remains to be fully established.
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regulation of cholesterol loading [55]. Thus these ﬁndings clearly
identify the mitochondrial cholesterol pool as a novel mechanism
whereby cancer cells, particularlyHCC, resist chemotherapy and evade
Bax-mediated MMP and subsequent apoptosis.
5. Role of cardiolipin/peroxidized cardiolipin in cell death
Cardiolipin is a mitochondria-speciﬁc phospholipid, which plays an
essential role in the organization of mitochondrial electron-transport
complexes involved in the generation of energy [27]. Indeed, cardiolipin
dynamics regulate mitochondrial structural reorganization in prokary-
otes and eukaryotes at different levels, including oxidative phosphory-
lation complexes, cristae remodeling and energy transducing systems,
as reviewed recently [58]. Accumulating evidence suggests that this
unique lipid also has an active role in several of the mitochondria-
dependent steps of apoptosis, namely, in the regulation of MOM,
mobilization of cytochrome, and more recently, in the anchoring of
caspase-8 to mitochondria during death receptor-induced apoptosis
[59].Mature cardiolipin is synthesized by the sequential participation of
phospholipase A, which removes one saturated acyl chain to generate
monolysocardiolipin, and by tafazzin, a mitochondrial enzyme that
catalyzes the addition of an unsaturated chain to monolysocardiolipin
[60]. It provides a docking site for the interaction and activation of
proapoptotic Bcl-2 proteins (tBid) in intact mitochondria [61], while
studies in liposomes and outer mitochondrial membrane vesicles
demonstrated the requirement for intact cardiolipin in the bilayer for
efﬁcient poration by active Bax [26]. Thus, these data indicate that
cardiolipin cooperates with Bax to form large-scale openings indepen-
dently of the formation of large (N100 kDa) Bax aggregates. Besides the
role of cardiolipin in Bax-mediated MOM permeabilization, cardiolipin
has an important function in the attachment of cytochrome c to MIM
and in themodulationof its release from IMS.Anadditional role involves
the generation of a peroxidase complex brought about between
cytochrome c–cardiolipin interactionwhichcontributes to theoxidationof cardiolipin into peroxidized cardiolipin [32]. Although the generation
of peroxidized cardiolipin from intact cardiolipin contributes to the
detachment of cytochrome c from the inner membrane, the exact
mechanism whereby peroxidized cardiolipin facilitated MOM permea-
bilization and cytochrome c release was unclear. In this regard, we
examined this critical issue using primary hepatocyteswhich have been
selectively depleted ofmGSH. First,we observed thatmGSHcontrols the
formation of cardiolipin peroxidation during TNF-mediated hepatocel-
lular cell death by regulating ROS generation [30] (Fig. 1). Hepatocytes
selectively depleted ofmGSHpharmacologically potentiated cardiolipin
peroxidation induced by TNF by a mechanism dependent on acidic
sphingomyelinase (ASMase), as ASMase deficiency impaired TNF-
induced peroxidized cardiolipin despite mGSH depletion. Intriguingly,
this outcome was observed despite the maintenance of glutathione
peroxidase and thioredoxin-III functional activities, indicating the
critical role of mGSH in the scavenging of mitochondrial peroxide gen-
eration. In addition, using liposomes mimicking the composition of
mitochondrial outer membrane entrapping ﬂuorescent dextrans, we
observed that the incorporation of peroxidized cardiolipin in the bilayer
enhanced the pore forming activity of active Bax by restructuring the
lipid bilayer through a mechanism promoting the lamellar-to-inverted
hexagonal lipid phase transition [30]. Thus, peroxidized cardiolipin
seems to play a dual role in mitochondrial apoptosis, facilitating the
mobilization of cytochrome c from the inner membrane available for
release while promoting the ability of Bax to permeabilize MOM.
Another novel function of cardiolipin in cell death has been the
recently described effect in regulating the activation of apycal caspase-
8 in type II cells [59]. Followinganexternal stimuli, caspase-8 translocated
to mitochondria to bind to sites enriched in cardiolipin resulting in its
proteolytic activation. Interestingly, recent evidence indicated that these
activating platforms enriched in cardiolipin corresponds to sites also
enriched in ganglioside GD3 and cholesterol, suggesting the presence
of raft-like domains, which have been described in cells undergoing
apoptosis [62,63]. Therefore, cardiolipin is an essential constituent of
speciﬁc microdomains, localized at contact sites between the inner and
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integrating signals from a variety of death-inducing proteins to bring in
close proximity caspase-8 and Bid to generate tBid where it is needed. In
line with this emerging view, the oxidation of cardiolipin would imply
the generation of its peroxidized form in sites close to MOM, facilitating
the permeabilizing activity of oligomerized Bax. A critical aspect derived
from the above considerations implies the redistribution of cardiolipin
from the inner to the outer membrane to comply with the various steps
of mitochondrial apoptosis it regulates (e.g. MOM permeabilization,
cytochrome cmobilization). The underlying mechanism involved in the
intramitochondrial trafﬁcking of cardiolipin during apoptosis is not yet
fully understood, although there is evidence indicating a multifactorial
nature in this process. Mitochondrial creatine kinase has been shown to
regulate the density of contact sites within mitochondrial membranes
where cardiolipin has been shown to reside [64]. In addition, Bid and
mostly tBid exhibit lipid transfer activity contributing to the transbilayer
movement of cardiolipin to the outer membrane [65,66]. Moreover,
phospholipid scramblases (PLS) inducenon-speciﬁcbi-directionalmove-
ment of phospholipids across the membrane. In particularly PLS3, a
mitochondrial located PLS, has been shown to translocate cardiolipin
from the MIM to the MOM during apoptosis induced by UV-irradiation
[67,68]. Nevertheless, regardless of the exact mechanism(s) involved,
the translocation of cardiolipin between mitochondrial membranes
has profound consequences in the mitochondrial apoptotic pathway,
regulating the release of cytochrome c, mitochondrial bioenergetics and
membrane perturbing effects such as the formation of cardiolipin-
enriched microdomains, cristae remodeling and the accumulation of
lyso-phospholipids. Further studies will be needed to establish if
cholesterol, sphingolipids (e.g. GD3) and (peroxidized) cardiolipin are
part of speciﬁc signaling domains which regulate the critical steps of
mitochondrial pathways of cell death.
Thus, consistent with the fundamental role of cardiolipin in
mitochondrial structural organization, it is conceivable that the oxida-
tion of cardiolipin contributes to the loss of mitochondrial function
and the regulation of the different steps of mitochondrial apoptosis,
such as MOMP, cytochrome cmobilization and release. However, this
scenariomay be speciﬁc for Bax-mediated but not for oxidant induced
MOMP and cell death. In the case of Bax activation brought about by
TNF, cardiolipin peroxidation stimulated the release of cytochrome c
and Smac/Diablo in mouse hepatocytes following TNF exposure [30].
Intriguingly, recent ﬁndings in oxidant-mediated release of mito-
chondrial apoptogenic proteins indicated a correlation between the
mitochondrial release of cytochrome c and the content of Gpx4 in
mitochondria from mice overexpressing or lacking Gpx4 [69].
Although, the level of ROS generation was not reported and the
content of peroxidized cardiolipin was indirectly assessed by 10-N-
nonyl acridine orange, the release of Smac/Diablo and Omi/HtrA2
was unaffected by the extent of Gpx4 content, indicating that the
effect of peroxidized cardiolipin is speciﬁc for cytochrome c.
Moreover, these ﬁndings imply that MOMP is independent of Gpx4
and presumably from ROS and peroxidized cardiolipin [69]. Hence
while peroxidized cardiolipin may modulate cytochrome c mobiliza-
tion, its effect on MOMP via destabilization of the bilayer may be
restricted to Bax-mediated MOMP.
6. Conclusions
As an integral component, cholesterol plays an important role in
the structure, physical properties and function of biological mem-
branes. In particular, the mitochondrial cholesterol pool, which
represents aminor proportionof the total cholesterol load, is emerging
as an important factor in the regulation of mitochondrial membrane
permeabilization and cell death. The enrichment of cholesterol in
mitochondrial membranes determines the progression of liver and
neurodegenerative diseases, and the resistance of cancer cells to
current cancer therapy. Much of this effect of cholesterol is due tothe changes in physical properties of mitochondrial membranes,
especially in the appearance of lipid-ordered phases and subsequent
loss of membrane ﬂuidity that impairs mitochondrial function and
speciﬁc membrane carriers. In particular, cholesterol loading in mito-
chondrial membranes selectively affects the transport of GSH into the
matrix resulting in its depletion, which has a major impact on the
stimulation of oxidant species derived from mitochondrial electron-
transport chain. As a consequence, cardiolipin becomes peroxidized,
facilitating the redistribution of free cytochrome c to the intermem-
brane space and the permeabilization of mitochondrial outer mem-
brane by Bax. The novelty of the ﬁndings described thus far centers on
the dual role of cholesterol in cell death regulation. While in certain
pathological conditions such as steatohepatitis or neurodegeneration
the accumulation of cholesterol in mitochondrial membranes pro-
motes apoptotic cell death, cholesterol loading in mitochondria of
cancer cells contributes to resistance to cancer therapy. Much of this
paradoxical behavior of cholesterol resides on the regulation of
mitochondrial GSH stores, which it is known to play a fundamental
role in oxidative stress, cardiolipin maintenance and cell death
susceptibility. Accounting for its proapoptotic function, mitochondrial
cholesterol enrichment shown in liver diseases or neurodegeneration
leads tomitochondrial GSH depletion. In contrast, cancer cells manage
to maintain unrestricted transport of GSH in mitochondria despite
increased trafﬁcking of cholesterol resulting in decreased membrane
ﬂuidity. The mechanisms, however, responsible for the unexpected
maintenance of mitochondrial GSH in cancer cells in the face of
increased cholesterol loading is currently under investigation. Thus,
targetingmitochondrial cholesterol either by restraining its trafﬁcking
to or withinmitochondrial membranes via StAR familymembers or by
decreasing its availability (e.g. ezetimide or statins) may be of rele-
vance for a number of pathologies such as steatohepatitis, neurode-
generative diseases or cancer. Alternatively, modulating the content of
mitochondrial GSH either by increasing its levels by permeable GSH
prodrugs or selectively depleting pharmacologically may be of
potential beneﬁt in these pathologies.
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